We are live on ! Find out more
USNA icon

Usana Health Sciences

151 hedge funds and large institutions have $859M invested in Usana Health Sciences in 2017 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 51 increasing their positions, 51 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 15

38% more capital invested

Capital invested by funds: $621M → $859M (+$238M)

5% more funds holding

Funds holding: 144151 (+7)

3.81% more ownership

Funds ownership: 44.55%48.36% (+3.8%)

0% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 51

44% less call options, than puts

Call options by funds: $1.53M | Put options by funds: $2.73M

Holders
151
Holders Change
+7
Holders Change %
+4.86%
% of All Funds
3.42%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
24
Increased
51
Reduced
51
Closed
15
Calls
$1.53M
Puts
$2.73M
Net Calls
-$1.19M
Net Calls Change
-$1.12M
Name Holding Trade Value Shares
Change
Change in
Stake
Prudential Financial
51
Prudential Financial
New Jersey
$1.86M -$536K -8,006 -24%
CIC
52
Cornercap Investment Counsel
Georgia
$1.85M +$901K +13,465 +117%
CFA
53
Camarda Financial Advisors
Florida
$1.82M -$185K -2,768 -10%
First Trust Advisors
54
First Trust Advisors
Illinois
$1.75M +$416K +6,215 +36%
PP
55
PDT Partners
New York
$1.74M -$27.2K -407 -2%
FQ
56
First Quadrant
California
$1.68M +$166K +2,475 +12%
AG
57
Aperio Group
California
$1.67M +$629K +9,411 +72%
Connor, Clark & Lunn Investment Management (CC&L)
58
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.67M +$1.09M +16,250 +258%
GC
59
Globeflex Capital
California
$1.65M -$37.1K -555 -2%
California Public Employees Retirement System
60
California Public Employees Retirement System
California
$1.64M -$108K -1,612 -7%
LSV Asset Management
61
LSV Asset Management
Illinois
$1.57M
Millennium Management
62
Millennium Management
New York
$1.51M -$2.5M -37,301 -65%
JP Morgan Chase
63
JP Morgan Chase
New York
$1.48M +$167K +2,501 +14%
Swiss National Bank
64
Swiss National Bank
Switzerland
$1.45M +$120K +1,800 +10%
Robeco Institutional Asset Management
65
Robeco Institutional Asset Management
Netherlands
$1.35M
California State Teachers Retirement System (CalSTRS)
66
California State Teachers Retirement System (CalSTRS)
California
$1.35M -$24.9K -372 -2%
USAA
67
United Services Automobile Association
Texas
$1.3M
ZCM
68
Zebra Capital Management
Connecticut
$1.12M +$192K +2,876 +23%
Invesco
69
Invesco
Georgia
$1.04M -$3.01K -45 -0.3%
CS
70
Credit Suisse
Switzerland
$1.04M -$105K -1,565 -10%
Bessemer Group
71
Bessemer Group
New Jersey
$955K -$214K -3,200 -20%
Hotchkis & Wiley Capital Management
72
Hotchkis & Wiley Capital Management
California
$912K +$824K +12,312 New
CEP
73
Chicago Equity Partners
Illinois
$911K +$823K +12,305 New
ACI
74
AMP Capital Investors
Australia
$894K
SO
75
STRS Ohio
Ohio
$858K -$114K -1,700 -13%

USNA Hedge Fund Activity: Q4 2017 in Review

151 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q4 2017, worth a combined $859M — up 38% from $621M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new USNA positions and 15 closed out — a net gain of 9 holders — while 51 added to existing stakes and 51 trimmed.

The largest buyer was DZ Bank, adding an estimated $9.34M. The largest seller was Fidelity Investments, cutting an estimated $3.27M.

  • 151 institutional investors held Usana Health Sciences (USNA) as of Q4 2017, up from 144 in Q3 2017.
  • Funds reported $859M of Usana Health Sciences stock for Q4 2017, up 38% quarter-over-quarter.
  • 24 funds opened new Usana Health Sciences positions in Q4 2017 and 15 closed out, a net change of +9 holders.
  • The largest Usana Health Sciences buyer in Q4 2017 was DZ Bank, an estimated $9.34M added.
  • The largest Usana Health Sciences seller in Q4 2017 was Fidelity Investments, an estimated $3.27M sold.

Based on aggregated 13F filings for Q4 2017.